TOP TIERMARKET NEWSWIRE
News & sentiment

iShares Biotechnology ETF (IBB) — News & AI sentiment

iShares Biotechnology ETF (IBB) news roundup. 1 story in the past week, 3 over 30 days. Average 30-day sentiment is 50/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 63/100
30d stories
3
avg sentiment 50/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

IBB news in the last 24 hours, 7 days, 30 days and 90 days

How much IBB coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowIBB storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days163/100IBB headlines →
Last 30 days350/100IBB headlines →
Last 90 days1956.1/100IBB headlines →

Latest stories on IBB

6d ago
Sep 1
Aug 28
Aug 1
Aug 1
Jul 27
Jul 23
Jul 22
Jul 22
Jul 21
IBB ETF Holds Fewer Bets Than You Think
Yahoo Top50 · neutralgeneral
Jul 15
Jul 11
Jul 10
Jul 10
Jul 6
Jul 2
Jun 23
Jun 23
Jun 15
Jun 4
2 Ways to Play the Big Pharma Patent Cliff
MarketBeat58 · neutralgeneral
May 15
Open IBB in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →